ecrin-mdr-crcClinical2021IPD Sharing (as of November 2022): Undecided Description: Individual participant data that underline the results reported in publications of the study may be shared after de-identification. This may include text, tables, figures, and appendices. The study protocol, statistical analysis plan, and informed consent form will also be shared. Data may be shared with researchers who provide a methodologically sound proposal to achieve the aims outlined in the approved proposal.Stomach CancerKidney NeoplasmsLung CancerHead and Neck CancerColorectal CancerBladder CancerLiver CancerLung NeoplasmsPancreas CancerEsophageal CancerKidney CancerStomach NeoplasmsPancreatic NeoplasmsStomach CancerKidney NeoplasmsLung CancerColorectal CancerLiver CancerBladder CancerLung NeoplasmsPancreas CancerEsophageal CancerHead And Neck CancerKidney CancerPancreatic NeoplasmsStomach NeoplasmsObservationalhttps://newmdr.ecrin.org/Study/2372841United States3ECRIN MDRRecruitingfalseDNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)The primary objective of this study, DELFI-L101, is to train and test classifiers for lung cancer detection using the DELFI assay and other biomarker and clinical features.2021-03-152372841NCT04825834